AtheroNova Inc. announced that Erik SG Stroes, MD, Chair and Professor at the Department of Vascular Medicine at the Academic Medical Center (AMC), Amsterdam has joined the company as a member of the Clinical Advisory Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -26.67% |
2016 | AtheroNova Operations, Inc. Bankruptcy Case Dismissed | CI |
2015 | First Motion for Exclusivity Period Extension Approved For AtheroNova Operations, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-26.67% | 9.69K | |
+40.80% | 55.66B | |
-8.05% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+10.69% | 26.29B | |
-16.21% | 20.25B | |
+31.00% | 12.76B | |
+28.51% | 12.18B | |
-1.67% | 12.12B |
- Stock Market
- Equities
- AHROQ Stock
- News AtheroNova Inc.
- AtheroNova Inc. Appoints Dr. Erik Stroes to its Clinical Advisory Board